Emerging evidence indicates that the dysregulation of the transcriptional repressor REST/NRSF cell signaling and the consequent epigenetic remodeling represents a critical mechanism in the progression of the neurodegeneration associated with ischemia and AD [30, 31, 36, 37]. The gene discussed is REST; the disease is Alzheimer disease.